Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Parker

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
California Medicine|November 1, 1971
Excellence need not cost more. Relating a free clinic's services to the patient's convenience and feelingsL M Parker
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Doctor-patient communication and ethical issuesL M Parker
The New England Journal of Medicine|June 9, 1983
Leukemia after treatment of ovarian cancer with alkylating agentsL M Parker
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1973
The antibody response to polyinosinic polycytidylic acidL M Parker, A D Steinberg
Surgical Oncology Clinics of North America|October 1, 1995
Endocrine and cytotoxic therapies for the management of advanced local breast cancer. Current clinical investigationL M Parker, B A Bornstein
American Journal of Veterinary Research|December 1, 1978
High-dose methotrexate and leucovorin rescue in dogs with osteogenic sarcomaS M Cotter, L M Parker
Cancer Treatment Reports|January 1, 1978
N-trifluoroacetyladriamycin-14-valerate: additional mouse antitumor and toxicity studiesL M Parker, M Hirst, M Israel
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Oestrogen receptor downregulation: an opportunity for extending the window of endocrine therapy in advanced breast cancerM Piccart, L M Parker, K I Pritchard
Experimental Hematology|January 1, 1979
In vitro proliferation of hemopoietic stem cells in long-term marrow cultures: principles in mouse applied to manJ S Greenberger, M Sakakeeny, L M Parker
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1974
Mechanism of allograft rejection in New Zealand mice. II. Role of a serum factorM C Gelfand, L M Parker, A D Steinberg
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
California Medicine|November 1, 1971
Excellence need not cost more. Relating a free clinic's services to the patient's convenience and feelingsL M Parker
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Doctor-patient communication and ethical issuesL M Parker
The New England Journal of Medicine|June 9, 1983
Leukemia after treatment of ovarian cancer with alkylating agentsL M Parker
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1973
The antibody response to polyinosinic polycytidylic acidL M Parker, A D Steinberg
Surgical Oncology Clinics of North America|October 1, 1995
Endocrine and cytotoxic therapies for the management of advanced local breast cancer. Current clinical investigationL M Parker, B A Bornstein
American Journal of Veterinary Research|December 1, 1978
High-dose methotrexate and leucovorin rescue in dogs with osteogenic sarcomaS M Cotter, L M Parker
Cancer Treatment Reports|January 1, 1978
N-trifluoroacetyladriamycin-14-valerate: additional mouse antitumor and toxicity studiesL M Parker, M Hirst, M Israel
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Oestrogen receptor downregulation: an opportunity for extending the window of endocrine therapy in advanced breast cancerM Piccart, L M Parker, K I Pritchard
Experimental Hematology|January 1, 1979
In vitro proliferation of hemopoietic stem cells in long-term marrow cultures: principles in mouse applied to manJ S Greenberger, M Sakakeeny, L M Parker
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1974
Mechanism of allograft rejection in New Zealand mice. II. Role of a serum factorM C Gelfand, L M Parker, A D Steinberg
Pageof 7